STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial
STAT News · LC · trust 69/100
Ultragenyx said its experimental therapy for Angelman syndrome, a rare disease, showed no benefit compared to a sham treatment in a Phase 3 trial.
Read the original at STAT News →
Open in TruthVane →